Allergy Immunotherapy for the Reduction of Asthma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
WheezingAsthmaAllergy
Interventions
BIOLOGICAL

Allergen extracts (subcutaneous injections)

Allergy immunotherapy consists of regular subcutaneous injections of an individualized mixture of allergen extracts according to the allergy sensitization profile of each child. Increasing doses of allergen extract are given in 1-2 injections until a predetermined maintenance dose is reached. This maintenance dose varies by extract and accords to the general practice guidelines of immunotherapy. To increase safety, the cumulative monthly maintenance doses are divided into biweekly visits during the maintenance phase (year 2-3)

OTHER

Standard of care

standard of care asthma and allergy treatment

Trial Locations (1)

10461

Jacobi Medical Center, The Bronx

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Jacobi Medical Center

OTHER

lead

Albert Einstein College of Medicine

OTHER